Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 20 citing articles:

Hsa-miR-22-3p inhibits liver cancer cell EMT and cell migration/ invasion by indirectly regulating SPRY2
Shuaishuai Cui, Yuanyuan Chen, Yunfei Guo, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0281536-e0281536
Open Access | Times Cited: 15
Long non-coding RNA muskelin 1 antisense RNA as a potential therapeutic target in hepatocellular carcinoma treatment
Xijun Chen, Qingsong Ye, Zhigao Chen, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 12237-12247
Open Access | Times Cited: 20
Disulfidptosis in tumor progression
Senlin Wan, Cong Liang, Chunfeng Wu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Extracellular Vesicle-Related Non-Coding RNAs in Hepatocellular Carcinoma: An Overview
Giuseppa Augello, Alessandra Cusimano, Melchiorre Cervello, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1415-1415
Open Access | Times Cited: 3
Making Sense of Antisense lncRNAs in Hepatocellular Carcinoma
Nicola Mosca, Aniello Russo, Nicoletta Potenza
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8886-8886
Open Access | Times Cited: 8
Risk factors of primary liver cancer initiation associated with tumour initiating cell emergence: novel targets for promising preventive therapies
Arthur Brouillet, Fouad Lafdil
eGastroenterology (2023) Vol. 1, Iss. 1, pp. e100010-e100010
Open Access | Times Cited: 8
Cuproptosis-related lncRNAs predict the prognosis and immune response in hepatocellular carcinoma
Qiongyue Zhang, Yan Huang, Yu Xia, et al.
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 6, pp. 2051-2064
Closed Access | Times Cited: 12
A novel disulfidptosis-related lncRNA signature for predicting prognosis and potential targeted therapy in hepatocellular carcinoma
Hui Zhang, Jiaojie Wang, Ming Yang
Medicine (2024) Vol. 103, Iss. 4, pp. e36513-e36513
Open Access | Times Cited: 2
Analysis of long non-coding RNAs associated with disulfidptosis for prognostic signature and immunotherapy response in uterine corpus endometrial carcinoma
Bohan Li, Xiaoling Li, Mudan Ma, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
The interaction between ETS transcription factor family members and microRNAs: A novel approach to cancer therapy
Liwei Du, Yuchen Liu, Chenxi Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113069-113069
Open Access | Times Cited: 7
Identification and validation of a five-necroptosis-related lncRNAs signature for prognostic prediction in hepatocellular carcinoma
Hao Chen, Guimin Hou, Tian Lan, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37403-e37403
Open Access | Times Cited: 1
Advances in the study of the mechanism of action of miR‑22 in liver lesions (Review)
Minghe Wang, Xuejing Wang, Yanqi Wang, et al.
Oncology Letters (2024) Vol. 28, Iss. 5
Open Access | Times Cited: 1
Oncogenic lncRNA ZNFX1 antisense RNA 1 promotes osteosarcoma cells proliferation and metastasis by stabilizing serine and arginine‑rich splicing factor 3
Yang Zhang, Wenbo Xu, Yanlong Wang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 5962-5974
Open Access | Times Cited: 6
Development and validation of an ECM-related prognostic signature to predict the immune landscape of human hepatocellular carcinoma
Guozhi Wu, Yuan Yang, Rong Ye, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 6
A prognostic exosome-related LncRNA risk model correlates with the immune microenvironment in liver cancer
Duntao Su, Zeyu Zhang, Zhijie Xu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 5
Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma: A Review
Fan Bu, Shijie Yin, Ruiqian Guan, et al.
Medicine (2022) Vol. 101, Iss. 47, pp. e31747-e31747
Open Access | Times Cited: 4
Prognostic Signature Constructed of Seven Ferroptosis-Related lncRNAs Predicts the Prognosis of HBV-Related HCC
Wenwen Wang, Lifen Wang, Chunxia Song, et al.
Journal of Gastrointestinal Cancer (2023) Vol. 55, Iss. 1, pp. 444-456
Open Access | Times Cited: 2
Construction of a prognostic model for disulfidptosis-related long noncoding RNAs in R0 resected hepatocellular carcinoma and analysis of their impact on malignant behavior
Xuefeng Gu, YanYan Wei, Duo Shen, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Cell Cycle-Related LncRNA-Based Prognostic Model for Hepatocellular Carcinoma: Integrating Immune Microenvironment and Treatment Response
Lin Chen, Guozhi Wu, Tao Wu, et al.
Current Medical Science (2024)
Closed Access
A Novel Differentially Expressed Cuproptosis-Related lncRNAs Signature to predict the prognosis and immune characteristics of hepatocellular carcinoma
Chunlin Yin, Ming Gao, Yuansong Sun, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top